NDA 090326 describes LIOTHYRONINE SODIUM, which is a drug marketed by
Xgen Pharms,
Biocon Pharma,
Dr Reddys Labs Sa,
Mylan,
Sigmapharm Labs Llc,
Sun Pharm,
Teva Pharms Usa,
Watson Labs, and
Zydus, and is included in ten NDAs. It is available from
eighteen suppliers. Additional details are available on the
LIOTHYRONINE SODIUM profile page.
The generic ingredient in LIOTHYRONINE SODIUM is
liothyronine sodium. There are four
drug master file entries for this compound. Twenty
suppliers are listed for this compound. Additional details are available on the
liothyronine sodium profile page.